T1	Or 29 32	and
E1	Or:T1 
T2	Age 40 44	aged
E2	Age:T2 
T3	Eq-Comparison 45 59	18 to 60 years
E3	Eq-Comparison:T3 Value:T51 Operator:T52 Value:T53 Temporal-Unit:T54
T4	Observation 66 81	Body mass index
E4	Observation:T4 Name:T55
T5	Eq-Comparison 82 96	20 to 27 kg/m2
E5	Eq-Comparison:T5 Value:T56 Operator:T57 Value:T58 Unit:T59 Unit:T60
T6	Eq-Comparison 136 142	active
E6	Eq-Comparison:T6 Temporal-Period:T61
T7	Condition 143 169	inflammatory bowel disease
E7	Condition:T7 Name:T62
T8	Eq-Comparison 189 201	pre-existing
E8	Eq-Comparison:T8 Temporal-Period:T63
T9	Condition 202 216	Celiac disease
E9	Condition:T9 Name:T64
T10	Condition 218 251	exocrine pancreatic insufficiency
E10	Condition:T10 Name:T65
T11	Or 252 254	or
E11	Or:T11 
T12	Condition 255 280	small bowel malabsorption
E12	Condition:T12 Name:T66
T13	Eq-Comparison 300 306	active
E13	Eq-Comparison:T13 Temporal-Period:T67
T14	Condition 307 323	bowel malignancy
E14	Condition:T14 Name:T68
T15	Condition 343 360	diabetes mellitus
E15	Condition:T15 Name:T69
T16	Or 361 363	or
E16	Or:T16 
T17	Assertion 371 380	suspected
E17	Assertion:T17 
A1	Assertion-Type-Value E17 possible
T18	Condition 381 399	motility disorders
E18	Condition:T18 Name:T70
T19	Modifier 407 410	gut
E19	Modifier:T19 
T20	Condition 430 457	decompensated liver disease
E20	Condition:T20 Name:T71
T21	Eq-Comparison 472 474	on
E21	Eq-Comparison:T21 Temporal-Period:T72
T22	Drug 475 484	ezetimibe
E22	Drug:T22 Name:T73
T23	Or 485 487	or
E23	Or:T23 
T24	Drug 488 510	bile acid sequestrants
E24	Drug:T24 Name:T74
T25	Condition 533 541	pregnant
E25	Condition:T25 Name:T75
T26	Or 542 544	or
E26	Or:T26 
T27	Condition 545 558	breastfeeding
E27	Condition:T27 Name:T76
T28	Condition 579 592	renal disease
E28	Condition:T28 Name:T77
T29	Eq-Comparison 608 610	on
E29	Eq-Comparison:T29 Temporal-Period:T78
T30	Drug 611 625	benzodiazepine
E30	Drug:T30 Name:T79
T31	Modifier 641 648	cardiac
E31	Modifier:T31 
T32	Or 649 651	or
E32	Or:T32 
T33	Condition 652 671	respiratory disease
E33	Condition:T33 Name:T80
T34	Drug 692 702	medication
E34	Drug:T34 
T35	Eq-Comparison 710 725	preceding month
E35	Eq-Comparison:T35 Temporal-Period:T82 Temporal-Unit:T83
T36	Condition 745 759	hypersensitive
E36	Condition:T36 
T37	Drug 763 772	Revestive
E37	Drug:T37 
T38	Or 773 775	or
E38	Or:T38 
T39	Drug 780 790	ingredient
E39	Drug:T39 Name:T84
T40	Eq-Comparison 792 798	active
E40	Eq-Comparison:T40 Temporal-Period:T85
T41	Or 799 801	or
E41	Or:T41 
T42	Eq-Comparison 804 811	history
E42	Eq-Comparison:T42 Temporal-Period:T86
T43	Drug 819 823	drug
E43	Drug:T43 
T44	Eq-Comparison 824 847	within the last 5 years
E44	Eq-Comparison:T44 Operator:T87 Temporal-Period:T88 Value:T89 Temporal-Unit:T90
T45	Condition 867 880	GI malignancy
E45	Condition:T45 Name:T91
T46	Condition 882 890	GI tract
E46	Condition:T46 Name:T92
T47	Condition 892 905	hepatobiliary
E47	Condition:T47 
T48	Condition 907 917	pancreatic
E48	Condition:T48 
T49	Life-Stage-And-Gender 25 28	Men
A2	Life-Stage-And-Gender-Type T49 male
T50	Life-Stage-And-Gender 33 38	women
A3	Life-Stage-And-Gender-Type T50 female
T51	Eq-Value 45 47	18
T52	Eq-Operator 48 50	to
A4	Eq-Operator-Value T52 BETWEEN
T53	Eq-Value 51 53	60
T54	Eq-Temporal-Unit 54 59	years
A5	Eq-Temporal-Unit-Value T54 year
T55	Observation-Name 66 81	Body mass index
A6	Observation-Type-Value T55 vital
T56	Eq-Value 82 84	20
T57	Eq-Operator 85 87	to
A7	Eq-Operator-Value T57 BETWEEN
T58	Eq-Value 88 90	27
T59	Eq-Unit 91 93	kg
T60	Eq-Unit 94 96	m2
T61	Eq-Temporal-Period 136 142	active
A8	Eq-Temporal-Period-Value T61 present
T62	Condition-Name 143 169	inflammatory bowel disease
T63	Eq-Temporal-Period 189 201	pre-existing
A9	Eq-Temporal-Period-Value T63 past
T64	Condition-Name 202 216	Celiac disease
T65	Condition-Name 218 251	exocrine pancreatic insufficiency
T66	Condition-Name 255 280	small bowel malabsorption
T67	Eq-Temporal-Period 300 306	active
A10	Eq-Temporal-Period-Value T67 present
T68	Condition-Name 307 323	bowel malignancy
T69	Condition-Name 343 360	diabetes mellitus
T70	Condition-Name 381 399	motility disorders
T71	Condition-Name 444 457	liver disease
T72	Eq-Temporal-Period 472 474	on
A11	Eq-Temporal-Period-Value T72 present
T73	Drug-Name 475 484	ezetimibe
T74	Drug-Name 488 510	bile acid sequestrants
T75	Condition-Name 533 541	pregnant
T76	Condition-Name 545 558	breastfeeding
T77	Condition-Name 579 592	renal disease
T78	Eq-Temporal-Period 608 610	on
A12	Eq-Temporal-Period-Value T78 present
T79	Drug-Name 611 625	benzodiazepine
T80	Condition-Name 652 671	respiratory disease
T81	Stability 681 688	changes
A13	Stability-Value T81 change
T82	Eq-Temporal-Period 710 719	preceding
A14	Eq-Temporal-Period-Value T82 past
T83	Eq-Temporal-Unit 720 725	month
A15	Eq-Temporal-Unit-Value T83 month
T84	Drug-Name 780 790	ingredient
T85	Eq-Temporal-Period 792 798	active
A16	Eq-Temporal-Period-Value T85 present
T86	Eq-Temporal-Period 804 811	history
A17	Eq-Temporal-Period-Value T86 past
T87	Eq-Operator 824 830	within
A18	Eq-Operator-Value T87 LTEQ
T88	Eq-Temporal-Period 835 839	last
A19	Eq-Temporal-Period-Value T88 past
T89	Eq-Value 840 841	5
T90	Eq-Temporal-Unit 842 847	years
A20	Eq-Temporal-Unit-Value T90 year
T91	Condition-Name 867 880	GI malignancy
T92	Condition-Name 882 890	GI tract
